In summary, our results demonstrate that TGF-β signaling disruption by Smad4 deletion in T cells of NOD mice accelerates the development of type 1 diabetes and increases the incidence of the disease. The gene discussed is SMAD4; the disease is type 1 diabetes mellitus.